image

Orthopedic medical device company with 2 new biomimetic (tissue-like) spine implants (GelStix & GelFix) entering US clinical trials. Both implants have been approved in Europe (receiving CE-mark) for use in treating chronic low back pain due to degenerative disc disease (DDD) and spinal stenosis, respectively. GelActive Spine acquired the assets from Replication Medical and is the exclusive licensee.

Company’s Keywords:

Q How Many Employees Does This Company Have?

1

Q Which Industry Does This Company Belong To?

medical devices

Q What Is the Annual Income?

Q What Is the Technology of All the Company’s Website?

Outlook, GoDaddy Hosting, Mobile Friendly, Google Tag Manager

Q What Year Was the Company Founded?

2020

Rate us and Write a Review

Your review is recommended to be at least 140 characters long

image

building Own or work here? Claim Now! Claim Now!

imageYour request has been submitted successfully.

image